EOM Pharmaceuticals Holdings, Inc. (OTCMKTS:IMUC – Get Free Report) was up 49.3% during mid-day trading on Monday . The stock traded as high as $0.20 and last traded at $0.20. Approximately 10,443 shares changed hands during mid-day trading, an increase of 239% from the average daily volume of 3,085 shares. The stock had previously closed at $0.13.
EOM Pharmaceuticals Price Performance
The firm’s 50 day simple moving average is $0.13 and its 200-day simple moving average is $0.15.
About EOM Pharmaceuticals
Immunocellular Therapeutics, Ltd., a clinical-stage pharmaceutical company, focuses on the development of therapeutics and delivery technologies for the treatment of inflammatory conditions and ocular diseases. Its lead clinical asset is EOM613 solution, a peptide nucleic-acid solution with anti-inflammatory and pro-inflammatory effects on cytokines and chemokines for the treatment of cancer cachexia and rheumatoid arthritis.
Further Reading
- Five stocks we like better than EOM Pharmaceuticals
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Target Results Are Not a Retail Bellwether: Why the Dip Is a Buy
- How to Calculate Inflation Rate
- Williams-Sonoma Stock: Buy It and Never Let It Go
- Insider Buying Explained: What Investors Need to Know
- 5 Dividend ETFs to Buy and Hold Forever
Receive News & Ratings for EOM Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EOM Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
